Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential axitinib and survivin vaccination unlock curative PD-1 immunotherapy in renal carcinoma.

Oncoimmunology·2026
Same author

Medication Management Among Older Adults Living Alone With Cognitive Impairment.

JAMA internal medicine·2026
Same author

Disruption of the structural maintenance of chromosomes 5/6 complex enables tumor mutagenesis.

NAR cancer·2026
Same author

The Concise Guide to PHARMACOLOGY 2025/26: Introduction and Other Protein Targets.

British journal of pharmacology·2025
Same author

Tiling 16S rRNA Gene Amplicon Sequencing Identifies Bacterial Species Soon After Lung Transplant That Predict Acute Cellular Rejection.

Transplantation·2025
Same author

Structural Maintenance of Chromosomes 5/6 complex dysfunction enables tumor mutagenesis.

medRxiv : the preprint server for health sciences·2025

Related Experiment Video

Updated: Jun 19, 2026

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

Neuroinflammation in Parkinson's disease.

Jae-Kyung Lee1, Thi Tran, Malú G Tansey

  • 1Department of Physiology, The University of Texas Southwestern Medical Center, Dallas, TX, USA.

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|October 13, 2009
PubMed
Summary

Inflammation and oxidative stress drive Parkinson's disease (PD) neurodegeneration by affecting immune cells and the nigrostriatal pathway. Anti-inflammatory drugs may offer risk reduction, according to recent studies.

Related Experiment Videos

Last Updated: Jun 19, 2026

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Parkinson's disease (PD) involves progressive degeneration of the dopaminergic nigrostriatal pathway.
  • Inflammation-derived oxidative stress and neurotoxicity are key implicated factors.

Purpose of the Study:

  • To review hypotheses on immune cell roles in PD pathogenesis.
  • To discuss inflammatory mechanisms and their link to disease progression.
  • To examine the impact of systemic inflammation and gene-environment interactions on neuroinflammation and neurodegeneration.

Main Methods:

  • Review of animal and human studies.
  • Analysis of pre-clinical and clinical evidence.
  • Meta-analysis of epidemiological data on anti-inflammatory drug effects.

Main Results:

  • Microglia and immune cells play a significant role in PD.
  • Systemic inflammation can activate microglia in the central nervous system.
  • Synergistic effects between PD-associated genes and neuroinflammation accelerate neurodegeneration.

Conclusions:

  • Neuroinflammation is a critical component of Parkinson's disease progression.
  • Further research into anti-inflammatory strategies is warranted for PD risk reduction.